These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design. Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416 [TBL] [Abstract][Full Text] [Related]
7. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice. Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts. Cheng SL; Lin CH Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344 [TBL] [Abstract][Full Text] [Related]
9. LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD. Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Thach C; Patalano F; Banerji D; Int J Chron Obstruct Pulmon Dis; 2015; 10():1015-26. PubMed ID: 26082625 [TBL] [Abstract][Full Text] [Related]
10. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD. Liesker JJ; Bathoorn E; Postma DS; Vonk JM; Timens W; Kerstjens HA Respir Med; 2011 Dec; 105(12):1853-60. PubMed ID: 21802933 [TBL] [Abstract][Full Text] [Related]
11. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity. Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647 [TBL] [Abstract][Full Text] [Related]
12. Blood eosinophils as a marker of response to inhaled corticosteroids in COPD. Barnes NC; Sharma R; Lettis S; Calverley PM Eur Respir J; 2016 May; 47(5):1374-82. PubMed ID: 26917606 [TBL] [Abstract][Full Text] [Related]
13. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Lee JH; Lee YK; Kim EK; Kim TH; Huh JW; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Kim N; Seo JB; Oh YM; Lee SD Respir Med; 2010 Apr; 104(4):542-9. PubMed ID: 19926461 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome. Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033 [TBL] [Abstract][Full Text] [Related]
15. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial. Watz H; Tetzlaff K; Magnussen H; Mueller A; Rodriguez-Roisin R; Wouters EFM; Vogelmeier C; Calverley PMA Respir Res; 2018 Dec; 19(1):251. PubMed ID: 30545350 [TBL] [Abstract][Full Text] [Related]
16. Short- and long-term efficacy of fluticasone propionate in subjects with early signs and symptoms of chronic obstructive pulmonary disease. Results of the DIMCA study. van Grunsven P; Schermer T; Akkermans R; Albers M; van den Boom G; van Schayck O; van Herwaarden C; van Weel C Respir Med; 2003 Dec; 97(12):1303-12. PubMed ID: 14682412 [TBL] [Abstract][Full Text] [Related]
17. Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease. Rodriguez-Roisin R; Tetzlaff K; Watz H; Wouters EF; Disse B; Finnigan H; Magnussen H; Calverley PM Int J Chron Obstruct Pulmon Dis; 2016; 11():1973-81. PubMed ID: 27578972 [TBL] [Abstract][Full Text] [Related]
18. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study. Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of asthma resistant to moderate dose inhaled corticosteroid treatment on bronchial hyperresponsiveness. Fujimoto K; Yamaguchi S; Urushibata K; Hanaoka M; Koizumi T; Honda T; Kubo K Intern Med; 2006; 45(14):843-9. PubMed ID: 16908940 [TBL] [Abstract][Full Text] [Related]
20. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER; Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]